www.fiercebiotech.com Open in urlscan Pro
104.18.1.165  Malicious Activity! Public Scan

Form analysis
0 forms found in the DOM

Text Content

Webinar


BALANCING PRIORITIES IN THERAPEUTICS DEVELOPMENT: SIMULATION-GUIDED DECISION
MAKING

Jun 20, 2023 2:00pm ET
60 Minutes
Share
share on linkedin
share on twitter
share on facebook
share on email
copy link

Clinical trials are complex, time-consuming, and costly. But what if you could
use simulation to guide your decisions and optimize your trial design? In this
webinar, we'll discuss the power of simulation-guided trial design (SGTD) and
explain its benefits to clinical development strategies. Through the use of real
examples, we’ll dispel common myths about trial simulation and explore how SGTD
can drive better-informed decisions about your therapeutics. Whether you're a
C-suite executive, clinician or statistician, this webinar is a must-attend for
anyone looking to unlock the power of SGTD.

Contents: 

 * Explore the benefits of a simulation guided approach to trial design and
   clinical development.
 * Dispel common myths about the meaning of trial simulation.
 * Discuss how Simulation-Guided Trial Design can support communication with
   Boards and Investors. 
 * Illustrate the concept of simulation guided design with a real example and
   discuss how SGTD can help develop new therapeutics.


SPEAKERS


ARI BRETTMAN

Senior Managing Director
Blackstone Life Sciences

Ari Brettman is a Senior Managing Director in the Blackstone Life Sciences
group, focusing on investments across the firm's portfolio. Dr. Brettman
received his M.D. from Duke University and his AB in History and Science from
Harvard College before completing his residency in internal medicine and
fellowship in cardiology at Massachusetts General Hospital. He is a founding
member of the Board of Directors of Anthos Therapeutics and AvenCell and has
served on the boards of Praxis Precision Medicines and Essa Pharmaceuticals.


JESS BROWN

Global Clinical Lead
AstraZeneca

Jess Brown MD PhD is a Global Clinical Lead at AstraZeneca and has >5yrs
experience in Translational Medicine and Clinical Development. She is a Medical
Oncologist by training, with a research background in DNA repair.


ALBERT KIM

Physician-Scientist, Therapeutics Development Team
Cytel

Albert Kim, MD, PhD, FACC, FHRS is a physician-scientist with over 30 years of
interdisciplinary experience in clinical medicine and therapeutic product
development. His academic path travelled through Harvard, UCLA, BWH, FDA/DCD,
MGH, and UCSF. He then transitioned to the pharmaceutical industry with Novartis
and then Pfizer where he held leadership roles of increasing responsibility
across early and late clinical development, most recently as Clinical Research
Head for the Internal Medicine Research Unit. After over 12 years in pharma, Dr.
Kim joined Cytel in 2021 as Chief Medical Officer to lead enterprise wide
clinical and medical efforts.


NATALIA MUEHLEMANN

Vice President, Therapeutics Development Team
Cytel

Natalia Muhlemann, MD, MBA has over 20 years of experience in General
Management, Clinical Development, Business Development in Life Sciences.
 Natalia joined Cytel as VP, Therapeutic Development Team at Cytel, in 2020.
Prior to Cytel, she served as Global Category Head, Acute Care - Oncology -
Devices at Nestle Health Sciences. 

Natalia acts as Expert Jury member for European Commission's Innovation Council.
 Natalia holds an MD and MBA (IMD) and professional certifications in statistics
and data science.


JAMES MATCHAM

VP Statistical Strategic Consulting, Therapeutics Development Team
Cytel

James joined Cytel three years ago, where he leads a global team of consultants
in the delivery of strategic statistical advice to sponsors. He spent 5 years at
the Applied Statistics Research Unit at the University of Kent, followed by 21
years at Amgen, designing and analysing clinical trials for regulatory and
reimbursement submissions. He then spent 7 years at AstraZeneca as VP Early
Clinical Biometrics, where he introduced the routine use of adaptive design and
quantitative decision-making.


REGISTER HERE!

Already registered? Click here to login.
Date/Time:
Jun 20, 2023 2:00pm ET
Duration:
60 Minutes

 * Connect
   
   * The Team
   * Advertise
 * Join Us
   
   * Newsletters
   * Resources
   * RSS Feeds
 * Our Brands
   
   * Fierce Pharma
   * Fierce Biotech
   * Fierce Healthcare
 * Our Events
   
   * Life Sciences Events

©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy


Close

In order to deliver a personalized and enhanced site navigation, we store
information on how you use the site. By continuing to use this site and access
it's features, you are consenting to our use of cookies. For more information,
please see the Questex Privacy Policy.